We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Kitazato Corporation is a Japanese entity primarily focused on the research, development, production, and distribution of specialized medical devices and related supplies used in fertility treatment. Headquartered in Shizuoka, Japan, the company offers a comprehensive suite of products catering to reproductive medicine, including precision needles, catheters, and cannulas. Their offerings also extend to advanced vitrification media and equipment, sperm processing media and tools, in-vitro fertilization (IVF) culture media, microsurgical instruments, and various essential labware products. Founded in 1998, the firm was formerly known as Kitazato Biopharma Co., Ltd. Kitazato Corporation operates as a subsidiary under Kitasato Shoji Co., Ltd.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 368A.T and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
